Zobrazeno 51 - 60
of 89
pro vyhledávání: '"502"'
Autor:
Mitsuyoshi Ota, Masashi Momiyama, Yasushi Ichikawa, Itaru Endo, Jun Watanabe, Atsushi Ishibe, Hirokazu Suwa, Chikara Kunisaki
Publikováno v:
Journal of Clinical Oncology. 34:502-502
502 Background: Neoadjuvant chemotherapy for locally advanced rectal cancer is required to achieve tumor reduction when skipping routine use of preoperative radiation therapy. It is known that EGFR inhibitor has impact on early tumor shrinkage in met
Autor:
Stacey M Watkins, Guru Sonpavde, Jennifer Gordetsky, Gurudatta Naik, Pooja Ghatalia, Sejong Bae, Sunil Sudarshan
Publikováno v:
Journal of Clinical Oncology. 34:502-502
502 Background: Tumor infiltrating Programmed-Death (PD)-1 and FoxP3-expressing lymphocytes and macrophages appear to be associated with higher risk of recurrence in patients (pts) with ccRCC undergoing surgery for localized disease. We aimed to comb
Publikováno v:
Journal of Clinical Oncology. 33:12-12
12 Background: To evaluate the characteristics and malignancy rate of oval, circumscribed enhancing lesions seen on preoperative breast MRI in patients with breast cancer. Methods: From January 2010 through May 2013, a total number of 502 oval, circu
Autor:
Daniel J. Schaid, Clive S. Grant, James N. Ingle, James E. Krook, Jerry A. Katzmann, Nick J. Gonchoroff, Lester E. Wold, Thomas E. Witzig, James B. Gerstner, John F. Barlow
Publikováno v:
Journal of Clinical Oncology. 11:351-359
PURPOSE AND METHODS To help clarify the clinical utility of flow-cytometric parameters, we performed flow cytometry on archival paraffin-embedded primary breast cancers from 502 patients treated on two adjuvant chemotherapy protocols performed by the
Publikováno v:
Journal of Clinical Oncology. 33:502-502
502 Background: Some on-target adverse events such as hypertension or thrombocytopenia have been reported as biomarkers predicting the efficacy of sunitinib as first-line therapy for patients with metastatic renal cell carcinoma (mRCC). Decrease of r
Autor:
Vidya B. Viswanathan, Toni K. Choueiri, Brandon A. Mahal, David R. Ziehr, Paul Nguyen, Yu-Wei Chen, Michelle D. Nezolosky, Quoc-Dien Trinh
Publikováno v:
Journal of Clinical Oncology. 33:95-95
95 Background: To investigate whether pelvic lymph node dissection (PLND) reduces prostate cancer specific mortality (PCSM) in surgically-treated men with intermediate-risk prostate cancer (Pca). Methods: We identified 44,112 men diagnosed with inter
Autor:
Nooreen Sarah Alam, Sam Mayes, Corinne Faivre-Finn, David Ryder, Peter D. Dickinson, Christopher J Boylan, Catherine Coyle, Richard C. Walshaw, Anna Tran, Jacqueline E Livsey, Julia Stratford, John P Logue, Tony Elliot, James D. Wylie, Ananya Choudhury, Carl G Rowbottom
Publikováno v:
Journal of Clinical Oncology. 32:220-220
220 Background: Cone beam CT (CBCT) images can be acquired during delivery of rotational radiotherapy. We assessed the quality of simultaneous CBCTs captured during prostate radiotherapy and studied the effects of arc delivery time on image quality.
Autor:
Wataru Obara, Jun Teishima, Ryoichi Shiroki, Hideyasu Matsuyama, Masayuki Takahashi, Tsunenori Kondo, Yasuyuki Kobayashi, Yoshihiko Tomita, Takashi Saika, Ken Kishida, Hiro-omi Kanayama, Kenya Yamaguchi, Atsushi Takahashi, Sei Naito, Naoto Sassa, Shinohara Nobuo, Mototsugu Oya, Takuya Koie, Takeshi Ueda
Publikováno v:
Journal of Clinical Oncology. 32:502-502
502 Background: Sorafenib (SO), an earlier introduced kinase inhibitor, and sunitinib (SU), a standard first-line treatment drug for metastatic renal cell carcinoma (mRCC), were associated with progression-free survival (PFS) of 5.7 and 11 months (M)
Autor:
Aravind Shivasami, Joseph W. Wrin, David Cunningham, Georgia Arentz, Amanda R. Townsend, Chee Lee, Timothy J. Price, Maressa A. Bruhn, Niall C. Tebbutt, Jenny Hardingham
Publikováno v:
Journal of Clinical Oncology. 32:502-502
502 Background: There remains a need for predictive biomarkers in mCRC to better identify patients who clinically benefit from anti-VEGF therapy, in particular bevacizumab (BEV). The AGITG MAX trial compared capecitabine (C) with capecitabine (+/- mi
Publikováno v:
Journal of Clinical Oncology. 31:139-139
139 Backround: Complications from Influenza infection remain an important cause of morbidity and mortality among immunosuppressed children and adolescents. Seasonal Influenza vaccine has been shown to be both safe and effective in pediatric and adole